James P. Allison

The University of Texas MD Anderson Cancer Center

Publishes on Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Immune Cell Function and Interaction. 1.2k papers and 121k citations.

PubIndex Score98Top 2%How it's scored

🌟#5 Current Senior Leader in Immunotherapy and Immune Responses 🌟#7 Current Senior Leader in Cancer Immunotherapy and Biomarkers 🌟#10 Current Senior Leader in Immune Cell Function and Interaction

1.2kPublications

121kTotal Citations

#5in Immunotherapy and Immune Responses

First publication: 1974First senior author: 1971

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses Immune Cell Function and Interaction CAR-T cell therapy research T-cell and B-cell Immunology

Top publicationsby citations

Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma

Michael A. Postow, Jedd D. Wolchok, Margaret K. Callahan et al.|New England Journal of Medicine|2012

Cited by 2.1k

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

Martin A. Cheever, Lynn M. Matrisian, James P. Allison et al.|Clinical Cancer Research|2009

Cited by 1.4k

Cancer classification using the Immunoscore: a worldwide task force

Jérôme Galon, Noriyuki Sato, Franck Pagès et al.|Journal of Translational Medicine|2012

Cited by 803

The Next Decade of Immune Checkpoint Therapy

Padmanee Sharma, James P. Allison|Cancer Discovery|2021

Cited by 739

Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study

Naval Daver, Hagop M. Kantarjian, Guillermo Garcia‐Manero et al.|Cancer Discovery|2018

Cited by 570